BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10086675)

  • 1. Dysplastic gastroesophageal junction nodules--a precursor to junctional adenocarcinoma.
    Gangarosa L; Halter S; Mertz H
    Am J Gastroenterol; 1999 Mar; 94(3):835-8. PubMed ID: 10086675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of adenocarcinomas of the distal esophagus, "gastroesophageal junction," and "gastric cardia" with gastric pathology.
    Wijetunge S; Ma Y; DeMeester S; Hagen J; DeMeester T; Chandrasoma P
    Am J Surg Pathol; 2010 Oct; 34(10):1521-7. PubMed ID: 20871225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N; Mandich D; Ligato S
    Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
    Cameron AJ; Souto EO; Smyrk TC
    Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
    Stein HJ; von Rahden BH; Höfler H; Siewert JR
    Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the lower esophagus and the esophagogastric junction.
    Potet F; Fléjou JF; Gervaz H; Paraf F
    Semin Diagn Pathol; 1991 Aug; 8(3):126-36. PubMed ID: 1925120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Dis Esophagus; 2007; 20(1):36-41. PubMed ID: 17227308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
    Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
    Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus.
    Ormsby AH; Kilgore SP; Goldblum JR; Richter JE; Rice TW; Gramlich TL
    Mod Pathol; 2000 Jun; 13(6):614-20. PubMed ID: 10874664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].
    Burdiles P; Csendes A; Smok G; Braghetto I; Korn O
    Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus and Barrett's-related dysplasia.
    Goldblum JR
    Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
    Morales CP; Spechler SJ
    Am J Gastroenterol; 2003 Apr; 98(4):759-62. PubMed ID: 12738452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
    Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
    Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.